Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer

SH Park, K Fong, J Kim, F Wang, X Lu, Y Lee… - Science …, 2021 - science.org
Forkhead box protein A1 (FOXA1) is essential for androgen-dependent prostate cancer
(PCa) growth. However, how FOXA1 levels are regulated remains elusive and its …

Lecture notes on ridge regression

WN van Wieringen - arXiv preprint arXiv:1509.09169, 2015 - arxiv.org
The linear regression model cannot be fitted to high-dimensional data, as the high-
dimensionality brings about empirical non-identifiability. Penalized regression overcomes …

Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours

S Crucitta, F Cucchiara, R Mathijssen, J Mateo… - Cancer treatment …, 2022 - Elsevier
Molecular heterogeneity characterizes tumours' evolution and adaptation and, because of its
dynamics and continuous changes under external pressure, it is one of the major causes of …

[HTML][HTML] The importance of DNA methylation in prostate cancer development

CE Massie, IG Mills, AG Lynch - The Journal of steroid biochemistry and …, 2017 - Elsevier
After briefly reviewing the nature of DNA methylation, its general role in cancer and the tools
available to interrogate it, we consider the literature surrounding DNA methylation as …

Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy

E Pashaei, E Pashaei, M Ahmady, M Ozen, N Aydin - PloS one, 2017 - journals.plos.org
Background Prostate cancer (PCa) is a leading reason of death in men and the most
diagnosed malignancies in the western countries at the present time. After radical …

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

A Ali, B Mekhaeil, OD Biziotis, EE Tsakiridis… - Communications …, 2023 - nature.com
Radiotherapy is a non-invasive standard treatment for prostate cancer (PC). However, PC
develops radio-resistance, highlighting a need for agents to improve radiotherapy response …

Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer

XW Zhang, JY Li, L Li, WQ Hu, Y Tao, WY Gao… - Cell Death & …, 2023 - nature.com
The widespread application of antiandrogen therapies has aroused a significant increase in
the incidence of NEPC, a lethal form of the disease lacking efficient clinical treatments. Here …

Genomic amplifications and distal 6q loss: novel markers for poor survival in high-risk neuroblastoma patients

P Depuydt, V Boeva, TD Hocking… - JNCI: Journal of the …, 2018 - academic.oup.com
Background Neuroblastoma is characterized by substantial clinical heterogeneity. Despite
intensive treatment, the survival rates of high-risk neuroblastoma patients are still …

Gene regulatory mechanisms underpinning prostate cancer susceptibility

T Whitington, P Gao, W Song, H Ross-Adams… - Nature …, 2016 - nature.com
Molecular characterization of genome-wide association study (GWAS) loci can uncover key
genes and biological mechanisms underpinning complex traits and diseases. Here we …

Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy

R Abou Khouzam, HV Goutham, RF Zaarour… - Seminars in cancer …, 2020 - Elsevier
Immunotherapy is poised to become an increasingly utilized therapy in the treatment of
cancer. However, several abnormalities in the tumor microenvironment (TME) that can …